Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Matrix metalloproteinase inhibitors: a structure-activity study

D E Levy1, F Lapierre, W Liang

  • 1Department of Chemistry, Glycomed, Inc., Alameda, California 94501, USA.

Journal of Medicinal Chemistry
|February 11, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parallel Impedivity Measurements for Enzyme Activity Quantification in Microtiter Plates for Calcite Precipitation Research.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Differential effect by chronic disease risk: A secondary analysis of the ChooseWell 365 randomized controlled trial.

Preventive medicine reports·2024
Same author

Case series: Computed tomography (CT) demonstrates lacrimal canal involvement in koalas (Phascolarctos cinereus) with maxillary incisor dental disease.

Australian veterinary journal·2022
Same author

Radiographic and CT appearance of cavitary pulmonary lesions in a lamb.

Australian veterinary journal·2021
Same author

A randomised controlled masked clinical trial of two treatments for osteoarthritis in dogs.

Australian veterinary journal·2021
Same author

Compartmental fat distribution in the abdomen of dogs relative to overall body fat composition.

BMC veterinary research·2020
Same journal

Small Molecules in Development for the Treatment of Sepsis: Insights into Drug Targets and Molecular Mechanisms.

Journal of medicinal chemistry·2026
Same journal

Isofagomine Derivatives as TcdB Glucosyltransferase Inhibitors.

Journal of medicinal chemistry·2026
Same journal

The One-Step Incorporation of Boron-10 Atom into Prostate Cancer-Targeted Fluorophores for Visualizing In Vivo Boron-10 Delivery and Intratumoral Distribution with Cellular Resolution.

Journal of medicinal chemistry·2026
Same journal

Design and Evaluation of Conformationally Locked Indole-Carboxylic Acids as Selective THRβ Agonists against MASH.

Journal of medicinal chemistry·2026
Same journal

Drug Screening of Nitroreductase Modulators Using an Atomic-Engineered Activatable Fluorescent Probe for Tumor Imaging.

Journal of medicinal chemistry·2026
Same journal

Reprogramming Acetaminophen Metabolism via Amide-to-Thioamide Modification to Prevent Drug-Induced Liver Injury.

Journal of medicinal chemistry·2026
See all related articles

Researchers explored modifications to hydroxamic acid-based matrix metalloproteinase inhibitors. Key findings reveal essential structural features for potent enzyme inhibition, including hydrogen bonds and zinc-binding groups.

Area of Science:

  • Medicinal Chemistry
  • Enzyme Inhibitor Design
  • Biochemistry

Background:

  • Matrix metalloproteinases (MMPs) are implicated in various diseases.
  • Hydroxamic acid-based inhibitors are a known class of MMP modulators.
  • Understanding structure-activity relationships is crucial for drug development.

Purpose of the Study:

  • To investigate structural modifications of hydroxamic acid-based MMP inhibitors.
  • To identify key structural requirements for potent enzyme inhibition.
  • To explore variations in amino acid residues and substituent groups.

Main Methods:

  • Synthesis of novel hydroxamic acid derivatives.
  • Incorporation of diverse amino acids (natural, unnatural, synthetic).
  • Modification of P1' and P3' substituents.

Related Experiment Videos

Main Results:

  • Potent inhibitors require two critical enzyme-substrate hydrogen bonds.
  • Effective zinc-binding functionalities are essential for inhibitor potency.
  • Larger hydrophobic R3 groups enhance potency against stromelysin.
  • Stromelysin exhibits more restrictive amino acid requirements than other MMPs.

Conclusions:

  • Specific structural features dictate MMP inhibitor efficacy.
  • Hydrogen bonding and zinc chelation are vital for potent inhibition.
  • Amino acid selection and hydrophobic interactions are critical for targeting specific MMPs like stromelysin.